A 華潤萬象生活有限公司 China Resources Mixc Lifestyle Services Limited (Stock Code 股份代號: 01209.HK) INTERIM RESULTS ANNOUNCEMENT Two Decades of Heritage A New Horizon of Legacy CONTENTS R Results Highlights 2 Financial Review 3 Business Review 4 ESG 2 2 Results Highlights Advanced to consolidate stability, achieved resilient growth, and fulfilled our commitment to value creation for shareholder. Commercial Management Business Overall RMB 8.524 billion Revenue YoY +6.5 % 37.1% Overall Gross Profit Margin YoY +3.1 pt RM ...

C O N T E N T S I . Strategy and business development 2025 Interim Results August 27, 2025 II. Key financials Strategy and business development PART ONE 01 P A R T Internationalization - Maintain the leading position in China and achieve integrated growth across domestic and international markets Digitalization - Improve operational efficiency and develop digital products ❖ Build a diversified product ecology and scale operations ❖ Meet or exceed customer needs with complete product solutions China's leadin ...

2025 Interim Results Win-win Situation with Customers Growing Profit by Increasing Sales Volume Value Creation through Diverse Energy Products and Services 2025.8.27 Business Highlights Core profit reached RMB3.22 bn, core profit from domestic businesses increased by 0.7% yoy to RMB3.1 bn Retail gas sales volume increased by 1.9% yoy to 12.95 bn m3 , with the newly installed designed daily capacity of 6.29 mn m3 for C/I customers, and newly developed 692,000 residential household customers Gross profit of I ...

Innovent Biologics 2025 Interim Results Advancing toward a New Era of Growth and Global Innovation August 2025 Agenda and Speakers | Business Review and Outlook | Dr. Michael Yu | Founder, Chairman of the Board, CEO | | --- | --- | --- | | R&D Highlight Updates | Dr. Hui Zhou Dr. Lei Qian | Chief R&D Officer, Oncology Chief R&D Officer, General Biomedicine | | Financials and Summary | Ms. Rachel You | Chief Financial Officer | | Q&A | Management Team | | Confidential Copyright© 2025 Innovent 2025H1: Continu ...

2025 Interim Results —Resilience and Innovation Expertise Makes Life Easier Financial Results Fu Xin Group Senior Vice President, and Group CFO August 2025 Cautionary Statements Regarding Forward-Looking Statements To the extent any statements made in this Report contain information that is not historical, these statements are essentially forward-looking. These forward-looking statements include but are not limited to projections, targets, estimates and business plans that the Company expects or anticipates ...

2025 Interim Results Investor Presentation August 2025 Contents 1. Results Highlights 5. ESG Development 2. Scale & Profitability Strengths 6. Outlook 3. Financial Stability Strengths 7. Appendices 4. Competitive Development Strengths Beijing | Corniche 1. Results Highlights 2025 Interim Results Highlights Sales remained among the top in the industry Contracted sales 120.15b Leading sales scale in first-tier cities Contracted sales in Hong Kong, Beijing, Shanghai, Guangzhou and Shenzhen 55.64b Leading marke ...

Disclaimer The information contained in this presentation is intended solely for your personal reference. In addition, such information contains projections and forward-looking statements that rellect the Company's current views with respect to future events and financial performance. These views are based on assumptions subject to various risks. No assurance can be given that future events will occur, that projections will be achieved, or that the Company's assumptions are correct. Actual results may diffe ...

FY 2024/25 ANNUAL RESULTS Analysts' Briefing 27 August 2025 Disclaimer This document and the information contained therein are intended to be distributed only to named or designated recipients, and it is not or should not be regarded as any advertisement or propaganda materials aimed to the non-specific public. It should not be reproduced quoted or transmitted in any form or manner or by any means, electronic or otherwise, in whole or in part, by the recipient or any other person, nor should it be redistrib ...

Financial Performance Highlights - The Group's insurance revenue reached RMB 280250 million, a 71% increase[101] - Net profit attributable to equity holders of the company increased by 140% to RMB 26671 million[19,101] - The Group's total investment yield (annualized) was 50%, up 09 percentage points[22,101] - Group consolidated net assets increased by 63% to RMB 3906 billion[20,41] Business Segment Performance - PICC P&C's insurance revenue grew by 56% to RMB 249040 million, with a combined ratio of 948%[57,101] - PICC Life's insurance revenue increased significantly by 325% to RMB 14018 million[68,101] - PICC Health saw a 132% rise in insurance revenue, reaching RMB 15603 million[74,101] Strategic Focus and Initiatives - The group premiums income increased by 64% to RMB 4546 billion[26] - Total insurance investment assets grew by 72% to RMB 17607 billion[32] - Business synergy generated RMB 16 billion in premiums income, an 89% increase[37] - The company is focused on strengthening core functions, promoting "Six Reforms," high-quality development, and risk prevention in the second half of 2025[90,91,92,93]

August 2025 2025 FIRST HALF RESULTS REVIEW O U R B U S I N E S S 2025 First Half Results Review ~ Stock Code: 0270 F I N A N C I A L H I G H L I G H T S 1 The unaudited consolidated profit attributable to owners of the Company for 1H25 increased by 11.2% to HK$2,682 million and interim dividend per share increased by 11.2% to HK$26.66 cents. 2 The net finance costs from continuing operations was decreased by HK$201 million to HK$188 million and net loss arising from fair value adjustments for investment pro ...